Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

HORIZON Pivotal Trial 3-Year Results

Ike Ahmed, MD, presents 3-year results of the HORIZON trial at ASCRS 2019. Dr. Ahmed highlights several key findings including the Hydrus Microstent as the first MIGS device to demonstrate significant long term reduction of severe major surgeries for mild to moderate glaucoma patients.